Dataset Information


Molecular Subtype-Specific Immunocompetent Models of High-Grade Urothelial Carcinoma Reveal Differential Neoantigen Expression and Response to Immunotherapy.

ABSTRACT: High-grade urothelial cancer contains intrinsic molecular subtypes that exhibit differences in underlying tumor biology and can be divided into luminal-like and basal-like subtypes. We describe here the first subtype-specific murine models of bladder cancer and show that Upk3a-CreERT2; Trp53L/L; PtenL/L; Rosa26LSL-Luc (UPPL, luminal-like) and BBN (basal-like) tumors are more faithful to human bladder cancer than the widely used MB49 cells. Following engraftment into immunocompetent C57BL/6 mice, BBN tumors were more responsive to PD-1 inhibition than UPPL tumors. Responding tumors within the BBN model showed differences in immune microenvironment composition, including increased ratios of CD8+:CD4+ and memory:regulatory T cells. Finally, we predicted and confirmed immunogenicity of tumor neoantigens in each model. These UPPL and BBN models will be a valuable resource for future studies examining bladder cancer biology and immunotherapy.Significance: This work establishes human-relevant mouse models of bladder cancer. Cancer Res; 78(14); 3954-68. ©2018 AACR.

PROVIDER: S-EPMC6157276 | BioStudies |

REPOSITORIES: biostudies

Similar Datasets

2018-04-12 | GSE112973 | GEO
2022-06-01 | GSE200005 | GEO
| S-EPMC7185218 | BioStudies
| S-EPMC6883615 | BioStudies
| S-EPMC4795170 | BioStudies
| S-EPMC7665011 | BioStudies
2017-01-01 | S-EPMC5561243 | BioStudies
| S-EPMC4881865 | BioStudies
| S-EPMC6627545 | BioStudies
| S-EPMC5886988 | BioStudies